Zaheer Muhammad Hammad, Zaheer Hamza, Tariq Arslan
Allama Iqbal Medical College, Lahore, Punjab 54700, Pakistan.
Services Institute of Medical Sciences, Lahore, Punjab 54000, Pakistan.
JBMR Plus. 2025 Jul 18;9(9):ziaf121. doi: 10.1093/jbmrpl/ziaf121. eCollection 2025 Sep.
Osteoporotic vertebral fractures represent a significant yet underdiagnosed manifestation of osteoporosis, particularly affecting older White women. While vertebral fractures are among the most common osteoporotic fractures, their contribution to mortality has received less attention compared to hip fractures, creating a critical knowledge gap. This study analyzed temporal trends in age-adjusted mortality rates from osteoporotic vertebral fractures among White women aged 65 and older in the United States from 1999 to 2020. We conducted a retrospective analysis using Centers for Disease Control and Prevention's Multiple Cause of Death files, identifying cases where both vertebral fractures and osteoporosis were listed as causes of death using specific ICD-10 codes. Age-adjusted mortality rates per 100 000 population were calculated using the 2000 US standard population, and joinpoint regression analysis identified significant changes in mortality trends over the 22-yr study period. Our findings revealed a concerning 87.5% increase in age-adjusted mortality rates, rising from 0.24 per 100 000 in 1999 to 0.45 per 100 000 in 2020. Joinpoint regression identified three distinct trend segments: a non-significant decline from 1999 to 2004, followed by a statistically significant increase from 2004 to 2009 with an annual percent change (APC) of 13.93%, and a more modest upward trend from 2009 to 2020. The overall average APC was 4.21%, indicating a highly significant upward trend in mortality rates. The pronounced increase during 2004-2009 coincides with important developments in osteoporosis management, including declining hormone replacement therapy use following Women's Health Initiative findings and emerging bisphosphonate safety concerns. These findings underscore vertebral fractures as potentially life-threatening complications requiring aggressive prevention and management strategies. As the population ages, our results highlight the urgent need for improved osteoporosis screening, enhanced fracture risk assessment, and optimized treatment approaches to reduce the growing burden of vertebral fracture-related mortality in this vulnerable population.
骨质疏松性椎体骨折是骨质疏松症一种显著但未得到充分诊断的表现形式,尤其影响老年白人女性。虽然椎体骨折是最常见的骨质疏松性骨折之一,但与髋部骨折相比,其对死亡率的影响较少受到关注,这造成了一个关键的知识空白。本研究分析了1999年至2020年美国65岁及以上白人女性因骨质疏松性椎体骨折导致的年龄调整死亡率的时间趋势。我们使用疾病控制和预防中心的多死因档案进行了一项回顾性分析,通过特定的国际疾病分类第十版(ICD - 10)编码识别出椎体骨折和骨质疏松症均被列为死因的病例。使用2000年美国标准人口计算每10万人口的年龄调整死亡率,连接点回归分析确定了22年研究期间死亡率趋势的显著变化。我们的研究结果显示,年龄调整死亡率令人担忧地上升了87.5%,从1999年的每10万人0.24例升至2020年的每10万人0.45例。连接点回归确定了三个不同的趋势阶段:1999年至2004年无显著下降,随后2004年至2009年有统计学意义的上升,年变化百分比(APC)为13.93%,2009年至2020年上升趋势较为平缓。总体平均APC为4.21%,表明死亡率呈高度显著的上升趋势。2004年至2009年期间的显著上升与骨质疏松症管理的重要发展相吻合,包括在妇女健康倡议研究结果发布后激素替代疗法使用的减少以及双膦酸盐安全性问题的出现。这些发现强调椎体骨折是可能危及生命的并发症,需要积极的预防和管理策略。随着人口老龄化,我们的结果凸显了迫切需要改进骨质疏松症筛查、加强骨折风险评估以及优化治疗方法,以减轻这一脆弱人群中与椎体骨折相关的不断增加的死亡负担。